Package 0904-6292-61

{"route": ["ORAL"], "spl_id": "cfa7738f-f1a2-41ef-975e-ffa8f94f1b44", "openfda": {"unii": ["YRZ789OWMI"], "rxcui": ["259255", "617311"], "spl_set_id": ["e74278b6-31fc-48d4-97b7-ba500e9e15fb"], "manufacturer_name": ["Major Pharmaceuticals"]}, "finished": true, "packaging": [{"sample": false, "description": "50 BLISTER PACK in 1 CARTON (0904-6292-06)  / 1 TABLET, FILM COATED in 1 BLISTER PACK", "package_ndc": "0904-6292-06", "marketing_start_date": "20141031"}, {"sample": false, "description": "100 BLISTER PACK in 1 CARTON (0904-6292-61)  / 1 TABLET, FILM COATED in 1 BLISTER PACK", "package_ndc": "0904-6292-61", "marketing_start_date": "20141031"}], "brand_name": "ATORVASTATIN CALCIUM", "product_id": "0904-6292_cfa7738f-f1a2-41ef-975e-ffa8f94f1b44", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["HMG-CoA Reductase Inhibitor [EPC]", "Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]"], "product_ndc": "0904-6292", "generic_name": "ATORVASTATIN CALCIUM", "labeler_name": "Major Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ATORVASTATIN CALCIUM", "active_ingredients": [{"name": "ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE", "strength": "40 mg/1"}], "application_number": "ANDA090548", "marketing_category": "ANDA", "marketing_start_date": "20141031", "listing_expiration_date": "20261231"}